Our radiopharmacy network develops, manufactures, and distributes PET and SPECT radiopharmaceuticals and associated educational services used in nuclear medicine and molecular imaging. In addition, we provide investigative and custom radiolabeling services to pharmaceutical, biotech, and research institutions worldwide, helping them develop the next generation of molecular imaging and therapeutic products.
The design of our PET cameras is based on the belief that molecular imaging should concentrate on the animals and user experience, instead of getting stuck with complicated machinery.
We think the real bottleneck of imaging is in the synthesis of PET probes. Based on our own needs for radiochemistry, we’ve built novel radiosynthesizers that address R&D and routine production needs.
We know a single PET probe can’t answer every question, so we’re investing in the development of new probes to interrogate the biology of disease.